Tempest Therapeutics Inc (TPST)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

7000 SHORELINE COURT SOUTH SAN FRANCISCO, CA 94080

Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

Data as of 2021-07-25 16:58:26 -0400
Market Cap285.836 Million Shares Outstanding19.043 Million Avg 30-day Volume1.86 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-20.1 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.03021 52-week High/Low41.55 / 10.39 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TPST instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 35 42 -16.67% 13 (0.76%) 16 (0.93%) -18.75%
13F shares: 6.989 Million 7.68 Million -8.99% 4.244 Million 4.441 Million -4.43%
% Ownership 36.7858 40.421 -8.99% 22.3369 23.3719 -4.43%
New Positions: 4 5 -20.0% 3 3 0.0%
Increased Positions 10 12 -16.67% 7 6 16.67%
Closed Positions 10 9 11.11% 6 5 20.0%
Reduced Positions 10 13 -23.08% 1 4 -75.0%
Total Calls 83 Thousand 23.1 Thousand 259.31% 51.5 Thousand
Total Puts 25.4 Thousand 0 15 Thousand 0
PUT/CALL Ratio 0.31 0.0 0.29
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TPST (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TPST BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MAESTAS NICHOLAS VP OF STRATEGY AND FINANCE

  • Officer
0 2021-07-12 2

NICHOL GEOFFREY

6,635 2021-07-01 1

WOIWODE THOMAS

6,635 2021-07-01 3

XU STELLA

6,635 2021-07-01 3

PELLIZZARI CHRISTINE A

0 2021-07-01 2

RAAB MICHAEL

0 2021-06-25 2

DUBENSKY THOMAS W. PRESIDENT

0 2021-06-25 2

LORENZO PIERRE CORPORATE CONTROLLER

0 2021-06-25 2

BRADY STEPHEN R CHIEF EXECUTIVE OFFICER

0 2021-06-25 2

WHITING SAMUEL CHIEF MEDICAL OFFICER

0 2021-06-25 2

VERSANT VENTURE CAPITAL VI, L.P.

VERSANT VENTURES VI GP, L.P.

VERSANT VENTURES VI GP-GP, LLC

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT VENTURES IV, LLC

VERSANT SIDE FUND IV, L.P.

  • 10% Owner
2,176,411 2021-06-25 1

OWENS JULIA C. EXECUTIVE CHAIR

  • Officer
  • Director
24,000 2021-03-17 1

ARCUDI III LOUIS J PRESIDENT AND CEO

  • Officer
  • Director
400,000 2021-02-26 1

MINAI-AZARY JENNIFER LYNN CHIEF FINANCIAL OFFICER

  • Officer
110,000 2021-02-26 2

HOWE JOHN P MD

  • Director
0 2020-06-22 0

DABLE HABIB J

  • Director
0 2020-06-22 0

HEDLEY MARY LYNNE

  • Director
0 2020-06-22 0

GALLAGHER CAROL GILTNER

  • Director
0 2020-06-22 0

NUECHTERLEIN CAROLE

  • Director
0 2020-06-22 0

HINDMAN JAMES M.

  • Director
0 2020-06-22 0

JOSEPH TAMARA L GENERAL COUNSEL AND SECRETARY

  • Officer
0 2020-05-25 0

ZEIDAN RYAN CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-05-25 0

ARBET-ENGELS CHRISTOPHE CHIEF MEDICAL OFFICER

  • Officer
0 2020-05-25 0

WHITCOMB RANDALL W

  • Director
0 2019-06-20 0

BRINZA JEFFERY M. SEC., CAO AND GENERAL COUNSEL

  • Officer
0 2019-01-15 0

MOHIDEEN PHARIS CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-15 0

ALDRICH RICHARD

  • Director
No longer subject to file 2018-12-07 0

KOZIN MARC D

  • Director
No longer subject to file 2018-12-07 0

FISHER MARY

  • Director
No longer subject to file 2018-12-07 0

GILLIS JONATHAN SENIOR VICE PRESIDENT, FINANCE

  • Officer
No longer subject to file 2018-12-07 0

KROEGER CHRISTOPHER A. CHIEF EXECUTIVE OFFICER

  • Officer
No longer subject to file 2018-12-07 0

LILLIE JAMES WOODRUFF CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2018-12-07 0

FHM VI, L.L.C.

FHM VI, L.P.

FRAZIER HEALTHCARE VI, L.P.

  • 10% Owner
1,396,615 2018-12-07 0

BARRIS PETER J

  • 10% Owner
1,766,407 2018-12-07 0

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

  • 10% Owner
1,766,407 2018-12-07 0

MOTT DAVID M

  • 10% Owner
1,766,407 2018-12-07 0

MAKOWER JOSHUA

  • 10% Owner
1,766,407 2018-12-07 0

MAKHZOUMI MOHAMAD

  • 10% Owner
1,766,407 2018-12-07 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
1,766,407 2018-12-07 0

BASKETT FOREST

  • 10% Owner
1,766,407 2018-12-07 0

SONSINI PETER W.

  • 10% Owner
1,766,407 2018-12-07 0

SANDELL SCOTT D

  • 10% Owner
1,766,407 2018-12-07 0

CAPELLO JEFFREY D

  • Director
0 2018-07-04 0

SEXTON JOHN

  • Director
0 2018-07-04 0

DIPP MICHELLE EXECUTIVE CHAIR

  • Officer
  • Director
0 2017-06-21 0

MALLEY THOMAS

  • Director
204,981 2017-06-13 0

COUTURIER CHRISTOPHE CHIEF FINANCIAL OFFICER

  • Officer
0 2017-03-02 0

CHAPMAN PAUL W.D. CHIEF OPERATING OFFICER

  • Officer
3,100 2016-05-10 0

STOCK HARALD F.

  • Director
266,422 2016-01-05 0

YOUNG JEFFREY E CHIEF FINANCIAL OFFICER

  • Officer
53,750 2015-12-03 0

TZIANABOS ARTHUR PRESIDENT AND CSO

  • Officer
26,400 2015-12-03 0

MCNEELY THERESA EVP, CHIEF COMM. OFFICER

  • Officer
400 2015-04-08 0

LONGWOOD FUND, L.P.

  • 10% Owner
No longer subject to file 2015-01-14 0

HARDING DAVID CHIEF COMMERCIAL OFFICER

  • Officer
0 2014-12-09 0

LAWTON ALISON FRANCIS CHIEF OPERATING OFFICER

  • Officer
0 2013-03-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MAESTAS NICHOLAS - Officer VP OF STRATEGY AND FINANCE

2021-07-14 16:27:15 -0400 2021-07-12 A 23,225 a 23,225 direct

WOIWODE THOMAS

2021-07-06 18:01:21 -0400 2021-07-01 A 6,635 a 6,635 direct

NICHOL GEOFFREY

2021-07-06 17:56:28 -0400 2021-07-01 A 6,635 a 6,635 direct

XU STELLA

2021-07-06 18:05:53 -0400 2021-07-01 A 6,635 a 6,635 direct

PELLIZZARI CHRISTINE A

2021-07-06 17:52:30 -0400 2021-07-01 A 6,635 a 6,635 direct

RAAB MICHAEL

2021-06-29 21:55:16 -0400 2021-06-25 A 16,784 a 16,784 direct

WHITING SAMUEL CHIEF MEDICAL OFFICER

2021-06-30 16:16:20 -0400 2021-06-25 A 540,231 a 540,231 direct

WHITING SAMUEL CHIEF MEDICAL OFFICER

2021-06-30 16:16:20 -0400 2021-06-25 A 201 a 201 direct 1.355 41.5537 41.5537 6 -5.2394 5

DUBENSKY THOMAS W. PRESIDENT

2021-06-29 21:55:26 -0400 2021-06-25 A 8,050 a 8,050 direct

DUBENSKY THOMAS W. PRESIDENT

2021-06-29 21:55:26 -0400 2021-06-25 A 111,343 a 111,343 direct -0.9839 -6.1717 18.4258 4 -6.1717 6

BRADY STEPHEN R CHIEF EXECUTIVE OFFICER

2021-06-29 21:54:45 -0400 2021-06-25 A 70,256 a 70,256 direct

WOIWODE THOMAS by versant venture capital iv, l.p.

2021-06-29 21:54:43 -0400 2021-06-25 A 1,171,094 a 1,171,094 indirect -0.9839 -6.1717 18.4258 4 -6.1717 6

LORENZO PIERRE CORPORATE CONTROLLER

2021-06-29 21:53:20 -0400 2021-06-25 A 1,234 a 1,234 direct

RAAB MICHAEL

2021-06-29 21:55:16 -0400 2021-06-25 A 4,830 a 4,830 direct

WHITING SAMUEL CHIEF MEDICAL OFFICER

2021-06-30 16:16:20 -0400 2021-06-25 A 3,018 a 3,018 direct

XU STELLA by quan venture fund i, l.p.

2021-06-29 21:56:06 -0400 2021-06-25 A 579,710 a 579,710 indirect -0.9839 -6.1717 18.4258 4 -6.1717 6

DUBENSKY THOMAS W. PRESIDENT

2021-06-29 21:55:26 -0400 2021-06-25 A 45,988 a 45,988 direct

BRADY STEPHEN R CHIEF EXECUTIVE OFFICER

2021-06-29 21:54:45 -0400 2021-06-25 A 1,982,250 a 1,982,250 direct

BRADY STEPHEN R CHIEF EXECUTIVE OFFICER

2021-06-29 21:54:45 -0400 2021-06-25 A 110,432 a 110,432 direct

WOIWODE THOMAS by versant venture capital vi, l.p.

2021-06-29 21:54:43 -0400 2021-06-25 A 997,940 a 997,940 indirect -0.9839 -6.1717 18.4258 4 -6.1717 6

LORENZO PIERRE CORPORATE CONTROLLER

2021-06-29 21:53:20 -0400 2021-06-25 A 4,830 a 4,830 direct

RAAB MICHAEL

2021-06-29 21:55:16 -0400 2021-06-25 A 9,660 a 9,660 direct

WHITING SAMUEL CHIEF MEDICAL OFFICER

2021-06-30 16:16:20 -0400 2021-06-25 A 61,945 a 61,945 direct

DUBENSKY THOMAS W. PRESIDENT

2021-06-29 21:55:26 -0400 2021-06-25 A 1,000,000 a 1,000,000 direct

DUBENSKY THOMAS W. PRESIDENT

2021-06-29 21:55:26 -0400 2021-06-25 A 36,263 a 36,263 direct

BRADY STEPHEN R CHIEF EXECUTIVE OFFICER

2021-06-29 21:54:45 -0400 2021-06-25 A 8,050 a 8,050 direct

WOIWODE THOMAS by versant side fund iv, l.p.

2021-06-29 21:54:43 -0400 2021-06-25 A 7,377 a 7,377 indirect -0.9839 -6.1717 18.4258 4 -6.1717 6

LORENZO PIERRE CORPORATE CONTROLLER

2021-06-29 21:53:20 -0400 2021-06-25 A 48,535 a 48,535 direct

LORENZO PIERRE CORPORATE CONTROLLER

2021-06-29 21:53:20 -0400 2021-06-25 A 53 a 53 direct -0.9839 -6.1717 18.4258 4 -6.1717 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TEMPEST THERAPEUTICS INC TPST 2021-07-28 22:15:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 21:45:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 21:15:02 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 20:45:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 20:15:04 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 19:45:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 19:15:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 18:45:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 18:15:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 17:45:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 17:15:03 UTC -93.4036 93.4836 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 16:45:03 UTC -97.5164 97.5964 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 16:15:02 UTC -97.5164 97.5964 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 15:45:03 UTC -97.5164 97.5964 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 15:15:03 UTC -97.5164 97.5964 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 14:45:02 UTC -99.5966 99.6766 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 14:15:03 UTC -99.5966 99.6766 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 13:45:02 UTC -99.5966 99.6766 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 13:15:03 UTC -99.5966 99.6766 35000
TEMPEST THERAPEUTICS INC TPST 2021-07-28 12:45:03 UTC -99.5966 99.6766 15000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments